COGNITIVE IMPAIRMENTS AS A SYMPTOM OF POST-COVID SYNDROME AMONG THE BULGARIAN POPULATION IN THE CONTEXT OF A GLOBAL PANDEMIC: AN ONGOING STUDY

Authors

  • Miroslava Hristova UMHAT “St. George”, Plovdiv, Clinic of Neurology, Bulgaria Author
  • Radka Massaldjieava Medical University of Plovdiv, Faculty of Public Health, Department of Health Care Management, Bulgaria Author

DOI:

https://doi.org/10.35120/medisij020225h

Keywords:

cognitive functions, cognitive impairments, post – COVID syndrome, neuropsychological test, COVID 19

Abstract

Isolated in China at the end of 2019, the novel Corona virus - SARS-CoV 2 spread worldwide with remarkable speed, causing a state of global health emergency just a few months later. And yet as we passed the acute phase of the COVID 19 pandemics, healthcare workers face the challenge of its late consequences. Therefore, the World Health Organization defined a new condition - post-COVID syndrome (PCS, Post-acute COVID Syndrome or long-COVID). According to several studies, the incidence of PCS varies from 10% to 35% among non-hospitalized patients and up to 85% among hospitalized patients. Moreover, various study results show that the syndrome affects both patients with a symptomatic form of the infection and those with an asymptomatic course. The syndrome itself presents with a wide range of non-specific complaints, most frequent of which are fatigue, shortness of breath and impaired cognitive functions. The exact pathogenetic mechanisms, responsible for these prolonged neuropsychological manifestations of long COVID 19 are yet to be established but most authors assume that they are caused by chronic neuroinflammation.

Purpose: The aim of our study is to assess the most common cognitive impairments among the Bulgarian population, thus providing information about their characteristics and incidence.

Methods and materials: We conducted a prospective study among 75 patients, all of which have recovered from COVID 19 infection at least 3 months prior to testing. All participants were between 20 and 60 years old and had no previous neurological or psychiatric disease. To assess cognitive functions, we used a computer test - the Cogstate Brief Battery, which provides a measure of four core cognitive domains: processing speed, attention, visual learning and working memory.

Results: The study is still ongoing, as we intend to conduct a follow-up testing on the sixth month. So far, our results are in accordance with findings in other countries, showing that executive functions and memory are predominantly affected. Therefore, it is important to underline the fact that there are objective findings for the non-specific subjective complaints.

Conclusion: Outlining the possible clinical features of long-COVID and emphasizing its undeniable medico-social meaning is of undeniable importance to healthcare workers. And given the progressively rising morbidity from this novel syndrome, a more precise description of these "cognitive impairments" is required in order to formulate epidemiologically based health strategies and ensure early prevention, especially in patients in an active age.

Downloads

Download data is not yet available.

References

Coronavirus disease (COVID-19) – World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019, посетен януари 2022г.

COVID-19. World Health Statistics. Geneva: World Health Organization; (https://www.who.int/data/gho/publications/world- health-statistics, посетен септември 2022г.

Varatharaj A., Ellul M., Davies N. et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psycairy 2020; 7:875-82; Published online June 25, 2020, https://doi.org/10.1016/ S2215-0366(20)30287-X

Whitaker M, Elliott J, Chadeau-Hyam M. et al. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv. 2021 https://doi.org/10.1101/2021.06.28.21259452 p. 2021.06.28.21259452.

Logue, J.K., Franko, N.M. McCulloch et al, 2021. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 4 (2), e210830. https://doi.org/10.1001/jamanetworkopen.2021.0830.

Frontera, J.A., Yang, D., Lewis, A., et al, 2021. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 426, 117486. https:// doi.org/10.1016/j.jns.2021.117486.

Walle-Hansen, M.M., Ranhoff, A.H., Mellingsæter, M. et al, 2021. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 21 (1), 199. https://doi.org/10.1186/s12877-021-02140-x.

Steven J. Lamontagne, Makaila F. Winters, Diego A. Pizzagalli, et al. Post-acute sequelae of COVID-19: Evidence of mood & cognitive impairment, Brain, Behavior, & Immunity - Health,Volume 17, 2021, 100347, SSN 2666-3546, https://doi.org/10.1016/j.bbih.2021.100347.

Ganna Blazhenets, Nils Schroeter, Tobias Bormann, et al. Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients; Journal of Nuclear Medicine Jul 2021, 62 (7) 910-915; DOI: 10.2967/jnumed.121.262128

Dabrowska E., Galinska-Skok G., Waszkiewicz N., Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life 2021,11,1056, https://doi.org/10.3390/ life11101056

Proal A. and VanElzakker M. et al,2021. Long COVID or Post-acute Sequelae of COVID-19 (PACS): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Frontiers in Microbiology, June 2021, Volume 12, Article 698169, doi: 10.3389/fmicb.2021.698169

Kempuraj D., Selvakumar G., Ejaz Ahmed M., et al. COVID-19, Mast cells, Cytokine storm, Psychological Stress and Neuroinflammation. The Neuroscientist

2020, Vol. 26(5-6) 402–41

Stefano G., Buttiker P., Weissenberger S.et al.; Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis. e-ISSN 1643-3750 © Med Sci Monit, 2021; 27: e933015 DOI: 10.12659/MSM.933015

Pacheco-Herrero M., Soto-Rojas L., Harrington C., et al, (2021). Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection. Front. Neurol. 12:660087. doi: 10.3389/fneur.2021.660087

Ribeiro D., Oliveira-Giacomelli A., Glaser T., et al. Hyperactivation of P2X7 receptors as a Culprit of COVID-19 Neuropathology. Molecular Psychiatry, 2020. https://doi.org/10.1038/s41380-020-00965-3

Borah P., Deb P., Chandrasekaran B., et al, 2021. Neurological Consequences of SARS- CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. Front. Mol. Biosci. 8:627723. doi: 10.3389/fmolb.2021.627723

Robinson-Agramonte M., Gonçalves C., Noris-García E., et al. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatr 2021; 11(7): 347-354

Sun,B.;Tang,N.;Peluso, M.J. et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells 2021, 10, 386. https://doi.org/ 10.3390/cells10020386

Downloads

Published

2023-05-18

How to Cite

COGNITIVE IMPAIRMENTS AS A SYMPTOM OF POST-COVID SYNDROME AMONG THE BULGARIAN POPULATION IN THE CONTEXT OF A GLOBAL PANDEMIC: AN ONGOING STUDY. (2023). MEDIS – International Journal of Medical Sciences and Research, 2(2), 25-28. https://doi.org/10.35120/medisij020225h